About the company
Pfizer, founded in 1849 by Charles Pfizer and Charles Erhart, has grown into a globally recognized powerhouse in the pharmaceutical industry. With a rich history spanning over 170 years, the company has consistently adapted to the changing landscape of healthcare and medical advancements. Pfizer's journey began with the production of chemicals and a diverse array of healthcare products. However, it strategically shifted its focus over time to become predominantly known for prescription drugs and vaccines. This strategic move has proven highly successful, especially in recent years as these segments now make up the majority of Pfizer's annual sales. Among Pfizer's top-selling products is the pneumococcal vaccine Prevnar 13. This vaccine has been instrumental in combatting pneumonia, a highly prevalent and dangerous respiratory infection, particularly in young children and the elderly. Prevnar 13 has demonstrated remarkable efficacy in preventing pneumonia caused by 13 strains of pneumococcus bacteria, making it a widely recommended vaccine across the globe. Another top-selling drug for Pfizer is Ibrance, a groundbreaking cancer medication that has revolutionized the treatment of hormone receptor-positive breast cancer. Ibrance, also known by its generic name palbociclib, is an oral therapy that specifically targets cancer cells to halt their growth. The drug has shown impressive results in clinical trials and has become a vital treatment option, providing hope for breast cancer patients. Pfizer's cardiovascular treatment, Eliquis, has also gained significant traction in the global market. Eliquis, developed in partnership with Bristol-Myers Squibb, is an anticoagulant that helps prevent blood clotting in patients with atrial fibrillation and other cardiovascular conditions. Its efficacy, coupled with its favorable safety profile, has made Eliquis an attractive option for physicians and patients alike. In the field of immunology, Pfizer's drug Xeljanz has made notable contributions. Xeljanz, or tofacitinib, is an oral therapy approved for the treatment of rheumatoid arthritis and psoriatic arthritis. By targeting specific molecules involved in the immune response, Xeljanz helps to alleviate symptoms and improve the quality of life for individuals living with these chronic autoimmune diseases. Pfizer's global reach is noteworthy, with international sales accounting for nearly 50% of the company's total sales. This global presence allows Pfizer to have a significant impact on healthcare worldwide. Emerging markets are an essential aspect of Pfizer's international sales, as the company recognizes the untapped potential and growing demand for pharmaceutical products in these regions. By focusing on emerging markets, which include countries like India, China, Brazil, and South Africa, Pfizer can not only expand its customer base but also address the healthcare needs of populations that have previously been underserved. These markets offer a unique opportunity for Pfizer to bring its life-saving medications and vaccines to individuals who may not have had access to such treatments previously. Pfizer's commitment to research and development is also a driving force behind its global success. The company invests heavily in discovering new therapies and advancing healthcare innovation. This dedication allows Pfizer to develop groundbreaking drugs and vaccines that can transform the lives of patients across the globe. Furthermore, Pfizer's commitment to corporate social responsibility is evident through its various initiatives. The company actively engages in philanthropic endeavors, supporting global health initiatives, as well as community-based programs that seek to improve access to healthcare and promote disease awareness. In conclusion, Pfizer's evolution into a pharmaceutical giant has been shaped by its strategic focus on prescription drugs and vaccines. With products like Prevnar 13, Ibrance, Eliquis, and Xeljanz leading the way, Pfizer has become a global leader in healthcare. The company's international sales, particularly in emerging markets, underscore its commitment to reaching diverse populations worldwide and improving global health outcomes. With its unwavering dedication to research and development, Pfizer continues to drive innovation and make a lasting impact on the lives of patients around the world.
Website: https://www.pfizer.com
Data updated: June 2, 2026
